¼¼°èÀÇ µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀå
Digital Diabetes Management
»óǰÄÚµå : 1768434
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 270 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀº 2030³â±îÁö 763¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 274¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀº 2024-2030³â¿¡ CAGR 18.6%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 763¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®Çϰí ÀÖ´Â ºÎ¹®ÀÇ ÇϳªÀÎ µð¹ÙÀ̽º´Â CAGR 18.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 467¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾ÖÇø®ÄÉÀÌ¼Ç ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 20.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 70¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 24.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀº 2024³â¿¡ 70¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 199¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 24.0%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 13.9%¿Í 16.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 15.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

µðÁöÅÐ ±â¼úÀÌ ´ç´¢º´ °ü¸®¸¦ ¾î¶»°Ô º¯È­½Ãų °ÍÀΰ¡?

Ç÷´ç ÃøÁ¤±â, ¸ð¹ÙÀÏ ¾Û, µ¥ÀÌÅÍ ºÐ¼® Ç÷§Æû°ú °°Àº µðÁöÅÐ ´ç´¢ °ü¸® ¼Ö·ç¼ÇÀº ´ç´¢º´ ȯÀÚÀÇ Áúº´ °ü¸® ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ½Ç½Ã°£ Ç÷´ç ¸ð´ÏÅ͸µ, °³ÀÎÈ­µÈ °Ç°­ ÀλçÀÌÆ®, ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇÏ¿© ȯÀÚ°¡ Ç÷´ç, Åõ¾à ½ºÄÉÁÙ, »ýȰ½À°ü µ¥ÀÌÅ͸¦ º¸´Ù È¿°úÀûÀ¸·Î ÃßÀûÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¸ð¹ÙÀÏ ¾Û°ú ¿þ¾î·¯ºí ±â±â´Â Áö¼ÓÀû Ç÷´ç ÃøÁ¤±â(CGM)¿Í ÅëÇյǾî ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô °Ç°­ ÁöÇ¥¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½Ã°¢À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µ¥ÀÌÅͺ£À̽º Á¢±Ù ¹æ½ÄÀº º¸´Ù Á¤È®ÇÑ ÀÇ»ç°áÁ¤À» Áö¿øÇϰí, ȯÀÚ°¡ ½Ç½Ã°£ Çǵå¹éÀ» ¹ÙÅÁÀ¸·Î ½Ä´Ü, ¿îµ¿, Àν¶¸° ¿ë·®À» Á¶Á¤ÇÏ¿© Ç÷´ç Á¶ÀýÀ» °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¿ø°ÝÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ȯÀÚÀÇ µ¥ÀÌÅ͸¦ ¿ø°ÝÀ¸·Î ÃßÀûÇϰí Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖÀ¸¸ç, ´ç´¢º´ °ü¸®¸¦ ´õ¿í °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. µðÁöÅÐ Ç÷§ÆûÀº ¶ÇÇÑ È¯ÀÚ¿Í ÀÇ·áÁø °£ÀÇ ¿øÈ°ÇÑ °Ç°­ µ¥ÀÌÅÍ °øÀ¯¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ´õ ³ªÀº ÀÇ»ç¼ÒÅë°ú º¸´Ù °³ÀÎÈ­µÈ Ä¡·á °èȹÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ç´¢º´ À¯º´·ü Áõ°¡¿Í ȯÀÚ Áß½É Ä¡·á·ÎÀÇ Àüȯ¿¡ µû¶ó µðÁöÅÐ ´ç´¢º´ °ü¸® ¼Ö·ç¼ÇÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÇ·áºñ¸¦ Àý°¨ÇÒ ¼ö ÀÖ´Â ±ÍÁßÇÑ Åø·Î Å« È£ÀÀÀ» ¾ò°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼Ç¿¡ AI¿Í ¿¹Ãø ºÐ¼®ÀÌ ÅëÇÕµÇ¸é ´ç´¢º´ Ä¡·á´Â ´õ¿í °³ÀÎÈ­µÇ°í, º¸´Ù È¿À²ÀûÀ̸ç, ȯÀÚ °³°³ÀÎÀÇ Çʿ信 ¸Â°Ô ¸ÂÃãÈ­µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀ» ÁÖµµÇÒ ½Å±â¼úÀº?

ÀΰøÁö´É, ¸Ó½Å·¯´×, IoT µî ½Å±â¼úÀÌ µðÁöÅÐ ´ç´¢ °ü¸® ½ÃÀåÀÇ ÃÖÀü¼±¿¡ ¼­¸é¼­ º¸´Ù °íµµÈ­µÇ°í ¿¹Ãø °¡´ÉÇÑ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÌ µîÀåÇϰí ÀÖÀ¸¸ç, AI ±â¹Ý ¾Ë°í¸®ÁòÀº Ç÷´ç ¼öÄ¡, ½Ä½À°ü, »ýȰ½À°ü µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ´ç´¢º´À» º¸´Ù È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ´Â °³ÀÎÈ­µÈ ÃßõÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿¹Ãø ºÐ¼®À» ÅëÇØ ȯÀÚ´Â ÀáÀçÀûÀÎ Ç÷´ç ±Þµî°ú ±Þ°­Çϸ¦ ¿¹ÃøÇÏ°í ¿¹¹æÇÒ ¼ö ÀÖÀ¸¸ç, ´ç´¢º´ °ü¸®°¡ º¸´Ù ´Éµ¿ÀûÀÌ°í ¸ÂÃãÇüÀ¸·Î ÀÌ·ç¾îÁú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ IoT ÅëÇÕÀ» ÅëÇØ ½º¸¶Æ® Àν¶¸° Ææ, ¿þ¾î·¯ºí CGM°ú °°Àº ±â±â°¡ ¸ð¹ÙÀÏ ¾Û ¹× ÇコÄɾî Ç÷§Æû°ú Åë½ÅÇÒ ¼ö ÀÖ°Ô µÇ¾î Áö¼ÓÀû À̰í Á¾ÇÕÀûÀÎ ´ç´¢º´ ¸ð´ÏÅ͸µÀ» Áö¿øÇÏ´Â ÀϰüµÈ »ýŰ踦 ±¸ÃàÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.

¶ÇÇÑ Ã·´Ü CGM, Àν¶¸° ÆßÇÁ, ÀÚµ¿ Àν¶¸° Àü´Þ ½Ã½ºÅÛ(Æó¼â ·çÇÁ ½Ã½ºÅÛ)ÀÇ °³¹ßÀº º¸´Ù Á¤È®Çϰí ÇÚÁîÇÁ¸®ÇÑ Ç÷´ç Á¶ÀýÀ» Á¦°øÇÔÀ¸·Î½á ´ç´¢º´ °ü¸®ÀÇ »óȲÀ» À籸¼ºÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ȯÀÚ¿¡°Ô ´õ Å« ÅëÁ¦·ÂÀ» Á¦°øÇÏ°í ¼öÀÛ¾÷À¸·Î ÀÎÇÑ °ü¸® ºÎ´ãÀ» ´ú¾îÁÝ´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ ºÎ»óµµ µðÁöÅÐ ´ç´¢º´ ¼Ö·ç¼ÇÀÇ Ã¤Åÿ¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ¿ø°Ý Áø·á, °¡»ó ¸ð´ÏÅ͸µ, Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ´ç´¢º´ Ä¡·á´Â º¸´Ù Á¢±Ù¼ºÀÌ ³ô°í, ½Å¼ÓÇϸç, µ¥ÀÌÅͺ£À̽ºÀÌ µÇ°í ÀÖÀ¸¸ç, µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀº Á¡Á¡ ´õ ±â¼ú¿¡ Á¤ÅëÇÑ È¯ÀÚ Áý´ÜÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù.

µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ´ç´¢º´ À¯º´·ü Áõ°¡¿Í º¸´Ù °³ÀÎÈ­µÈ µ¥ÀÌÅͺ£À̽º ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾Û, ¿þ¾î·¯ºí ±â±â, CGMÀÇ º¸±ÞÀ¸·Î ´ç´¢º´ °ü¸®°¡ ´õ¿í Ä£¼÷Çϰí Á¤È®ÇØÁ³À¸¸ç, ȯÀÚµéÀº ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ µðÁöÅÐ ´ç´¢º´ Åø¿¡ AI¿Í ¸Ó½Å·¯´×ÀÌ ÅëÇյǸ鼭 ¿¹Ãø ±â´ÉÀÌ °­È­µÇ¾î ȯÀÚ¿Í ÀÇ·áÁø¿¡°Ô Ç÷´ç Á¶ÀýÀ» °³¼±ÇÒ ¼ö ÀÖ´Â ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ȯÀÚ Áß½ÉÀÇ Ä¡·á¿Í ¹Ì·¡ÁöÇâÀû ÇコÄɾî Áõ°¡ Ãß¼¼¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·áºñ Áõ°¡¿Í ´ç´¢º´À¸·Î ÀÎÇÑ °æÁ¦Àû ºÎ´ãÀ» ÁÙ¿©¾ß ÇÑ´Ù´Â ¾Ð¹Úµµ µðÁöÅÐ ´ç´¢º´ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ COVID-19 ÆÒµ¥¹Í ÀÌÈÄ ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È®´ë´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô Çϰí Àû½Ã¿¡ ÀÇ·á °³ÀÔÀ» ÃËÁøÇÔÀ¸·Î½á äÅÃÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹, À¯·´ µîÀÇ ±¹°¡¿¡¼­´Â µðÁöÅÐ Çコ Åø¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø Á¤Ã¥°ú »óȯ ¸ðµ¨ÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â Æí¸®Çϰí Á¤È®ÇÑ ¹æ¹ýÀ» ã´Â ¼ÒºñÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó µðÁöÅÐ ´ç´¢º´ °ü¸® ½ÃÀåÀº ´ç´¢º´ Ä¡·á¿¡ º¸´Ù È¿À²ÀûÀÌ°í °³ÀÎÈ­µÈ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÔÀ¸·Î½á Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

Á¦Ç°&¼­ºñ½º(µð¹ÙÀ̽º, ¾ÖÇø®ÄÉÀ̼Ç, µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î & Ç÷§Æû, ¼­ºñ½º); µð¹ÙÀ̽º À¯Çü(¿þ¾î·¯ºí, ÇÚµåÇïµå)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Diabetes Management Market to Reach US$76.3 Billion by 2030

The global market for Digital Diabetes Management estimated at US$27.4 Billion in the year 2024, is expected to reach US$76.3 Billion by 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$46.7 Billion by the end of the analysis period. Growth in the Application segment is estimated at 20.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.0 Billion While China is Forecast to Grow at 24.0% CAGR

The Digital Diabetes Management market in the U.S. is estimated at US$7.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$19.9 Billion by the year 2030 trailing a CAGR of 24.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.9% and 16.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.0% CAGR.

Global Digital Diabetes Management Market - Key Trends & Drivers Summarized

How Is Digital Technology Transforming Diabetes Management?

Digital diabetes management solutions, including glucose monitors, mobile apps, and data analytics platforms, have revolutionized the way diabetes patients manage their condition. These technologies provide real-time glucose monitoring, personalized health insights, and remote monitoring capabilities, allowing patients to track blood glucose levels, medication schedules, and lifestyle data more effectively. Mobile apps and wearable devices can integrate with continuous glucose monitors (CGMs), giving patients and healthcare providers a comprehensive view of their health metrics. This data-driven approach supports more accurate decision-making, enabling patients to adjust their diet, exercise, and insulin doses based on real-time feedback, ultimately improving glycemic control.

Telemedicine and remote monitoring capabilities have further enhanced diabetes management by allowing healthcare providers to track patient data remotely and provide timely interventions. Digital platforms also allow for the seamless sharing of health data between patients and care teams, promoting better communication and more personalized treatment plans. With the rise in diabetes prevalence and the shift toward patient-centered care, digital diabetes management solutions have gained significant traction as a valuable tool for improving patient outcomes and reducing healthcare costs. The integration of AI and predictive analytics into these solutions is expected to further personalize diabetes care, making it more efficient and responsive to individual patient needs.

What Emerging Technologies Are Driving the Digital Diabetes Management Market?

Emerging technologies such as artificial intelligence, machine learning, and IoT are at the forefront of the digital diabetes management market, enabling more sophisticated and predictive healthcare solutions. AI-powered algorithms analyze blood glucose trends, dietary habits, and lifestyle data to provide personalized recommendations for managing diabetes more effectively. This predictive analysis allows patients to anticipate and prevent potential glucose spikes or drops, making diabetes management more proactive and tailored. Additionally, IoT integration enables devices like smart insulin pens and wearable CGMs to communicate with mobile apps and healthcare platforms, creating a cohesive ecosystem that supports continuous and comprehensive diabetes monitoring.

Moreover, the development of advanced CGMs, insulin pumps, and automated insulin delivery systems (closed-loop systems) is reshaping the diabetes management landscape by providing more precise and hands-free glucose regulation. These innovations offer patients greater control and reduce the burden of manual management. The rise of telemedicine has also contributed to the adoption of digital diabetes solutions, allowing for remote consultations, virtual monitoring, and timely interventions. With technological advancements making diabetes care more accessible, responsive, and data-driven, the digital diabetes management market is rapidly expanding to meet the needs of an increasingly tech-savvy patient population.

Growth in the Digital Diabetes Management Market Is Driven by Several Factors

Growth in the digital diabetes management market is driven by the increasing prevalence of diabetes globally and the demand for more personalized, data-driven healthcare solutions. The widespread adoption of mobile apps, wearable devices, and CGMs has made diabetes management more accessible and precise, allowing patients to monitor their health in real-time. Additionally, the integration of AI and machine learning in digital diabetes tools has enhanced predictive capabilities, providing patients and healthcare providers with actionable insights to improve glycemic control. This technological progress supports the growing trend toward patient-centered care and proactive health management.

Increased healthcare costs and the pressure to reduce the economic burden of diabetes are also fueling investment in digital diabetes management solutions. The expansion of telemedicine services, especially following the COVID-19 pandemic, has further accelerated adoption, enabling remote patient monitoring and facilitating timely healthcare interventions. Furthermore, supportive government policies and reimbursement models for digital health tools in countries like the United States and Europe are contributing to the market’s growth. As consumers increasingly seek convenient and accurate ways to manage chronic conditions, the digital diabetes management market is poised for continued expansion, offering a more efficient and personalized approach to diabetes care.

SCOPE OF STUDY:

The report analyzes the Digital Diabetes Management market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Service (Devices, Application, Data Management Software & Platforms, Services); Device Type (Wearable, Handheld)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â